Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epimutational profile of hematologic malignancies as attractive target for new epigenetic therapies
Elisabetta Fratta, Barbara Montico, Aurora Rizzo, et al.
Oncotarget (2016) Vol. 7, Iss. 35, pp. 57327-57350
Open Access | Times Cited: 25

Showing 25 citing articles:

Cancer epigenetics: Moving forward
Angela Nebbioso, Francesco Paolo Tambaro, Carmela Dell’Aversana, et al.
PLoS Genetics (2018) Vol. 14, Iss. 6, pp. e1007362-e1007362
Open Access | Times Cited: 417
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
Mrinal M. Gounder, Patrick Schöffski, Robin L. Jones, et al.
The Lancet Oncology (2020) Vol. 21, Iss. 11, pp. 1423-1432
Closed Access | Times Cited: 308
Metabiotics: The Functional Metabolic Signatures of Probiotics: Current State-of-Art and Future Research Priorities—Metabiotics: Probiotics Effector Molecules
Aarti Singh, Vishakha Vishwakarma, Barkha Singhal
Advances in Bioscience and Biotechnology (2018) Vol. 09, Iss. 04, pp. 147-189
Open Access | Times Cited: 80
FACER: comprehensive molecular and functional characterization of epigenetic chromatin regulators
Jianping Lu, Juan Xu, Junyi Li, et al.
Nucleic Acids Research (2018) Vol. 46, Iss. 19, pp. 10019-10033
Open Access | Times Cited: 80
Epigenetics in multiple myeloma: From mechanisms to therapy
Mohammad Alzrigat, Alba Atienza Párraga, Helena Jernberg‐Wiklund
Seminars in Cancer Biology (2017) Vol. 51, pp. 101-115
Closed Access | Times Cited: 76
Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma
Mark E. Issa, Farnaz Sedigheh Takhsha, Chandra Sekhar Chirumamilla, et al.
Clinical Epigenetics (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 74
Novel insights into epigenetic drivers of oropharyngeal squamous cell carcinoma: role of HPV and lifestyle factors
Paolo Boscolo‐Rizzo, Carlo Furlan, Valentina Lupato, et al.
Clinical Epigenetics (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 45
Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma
Carlo Furlan, Jerry Polesel, Luigi Barzan, et al.
Clinical Epigenetics (2017) Vol. 9, Iss. 1
Open Access | Times Cited: 36
Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression
Hsiang‐Cheng Chi, Chung‐Ying Tsai, Ming-Ming Tsai, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 555-555
Open Access | Times Cited: 32
Hypomethylating Agent Azacitidine Is Effective in Treating Brain Metastasis Triple-Negative Breast Cancer Through Regulation of DNA Methylation of Keratin 18 Gene
Christopher Butler, Samuel A. Sprowls, Gábor Szalai, et al.
Translational Oncology (2020) Vol. 13, Iss. 6, pp. 100775-100775
Open Access | Times Cited: 27
MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia
Doralina do Amaral Rabello Ramos, Vivían D’Afonseca, Maria Gabriela Berzoti-Coelho, et al.
Cancer Cell International (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 24
Epigenetic‐Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease
Juraj Adamik, G. David Roodman, Deborah L. Galson
JBMR Plus (2019) Vol. 3, Iss. 3
Open Access | Times Cited: 22
Cancer therapies in HIV cure research
Thomas A. Rasmussen, Jenny L. Anderson, Fiona Wightman, et al.
Current Opinion in HIV and AIDS (2016) Vol. 12, Iss. 1, pp. 96-104
Open Access | Times Cited: 19
Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma
Xi Yun Zhang, Deepa Rajagopalan, Tae‐Hoon Chung, et al.
Experimental Hematology and Oncology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Quantitative Methylation-Specific PCR: A Simple Method for Studying Epigenetic Modifications of Cell-Free DNA
Luca Sigalotti, Alessia Covre, Francesca Colizzi, et al.
Methods in molecular biology (2018), pp. 137-162
Closed Access | Times Cited: 16
Aberrant methylation and microRNA-target regulation are associated with downregulated NEURL1B: a diagnostic and prognostic target in colon cancer
Jiaxin Liu, Zhao Liu, Xiaozhi Zhang, et al.
Cancer Cell International (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
Sena Kim, Srikanth Santhanam, Sora Lim, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4281-4281
Open Access | Times Cited: 10
Methylation patterns of cutaneous T‐cell lymphomas
Katarzyna Iżykowska
Experimental Dermatology (2020) Vol. 30, Iss. 8, pp. 1135-1140
Open Access | Times Cited: 7
Analysis of contribution of protein phosphorylation in the development of the diseases
Maria G. Zavialova, Victor G. Zgoda, Е. Н. Николаев
Biomeditsinskaya Khimiya (2017) Vol. 63, Iss. 2, pp. 101-114
Open Access | Times Cited: 6
Analysis of the role of protein phosphorylation in the development of diseases
Maria G. Zavialova, Victor G. Zgoda, Е. Н. Николаев
Biochemistry (Moscow) Supplement Series B Biomedical Chemistry (2017) Vol. 11, Iss. 3, pp. 203-218
Closed Access | Times Cited: 5
Development of Pyrazine-Anilinobenzamides as Histone Deacetylase HDAC1–3 Selective Inhibitors and Biological Testing Against Pancreas Cancer Cell Lines
Mohamed Abdelsalam, Hany S. Ibrahim, Lukas Krauß, et al.
Methods in molecular biology (2022), pp. 145-155
Closed Access | Times Cited: 2
Pre-clinical Strategies to Overcome Drug-Resistant Multiple Myeloma: Predictive Transcriptomics and Targeting the Myeloma Epigenome
Taylor Harding
(2018)
Closed Access | Times Cited: 1
Aberrant Epigenomic Regulatory Networks in Multiple Myeloma and Strategies for Their Targeted Reversal
Samrat Roy Choudhury, Brian A. Walker
RNA technologies (2019), pp. 543-572
Closed Access | Times Cited: 1
Long non-coding RNAs (lncRNAs)-mediated epigenetic status is possibly involved in the susceptibility of periodontal disease
Shigeki Suzuki, Hang Yuan, Manatsu Kurita, et al.
Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology) (2019) Vol. 61, Iss. 1, pp. 1-8
Open Access
Clinical utility of solid tumor epigenetics
Engin Demirdizen, Julián Taranda, Şevin Turcan
Medical Epigenetics (2021), pp. 425-446
Closed Access
Page 1

Scroll to top